Which delivery method is recommended for bronchodilator therapy during pediatric asthma episodes?

Which delivery method is recommended for bronchodilator therapy during pediatric asthma episodes?

• A. Inhaled beta-agonist (albuterol) via nebulizer alone
• B. Inhaled beta-agonist (albuterol) via nebulizer or metered-dose inhaler with spacer; consider ipratropium for severe cases
• C. Oral albuterol syrup
• D. Intravenous albuterol

Answer: (B)

During pediatric asthma episodes, the goal is rapid, effective bronchodilation delivered directly to the lungs. Inhaled beta-agonists achieve this best, and they can be given either by a nebulizer or by a metered-dose inhaler with a spacer. The spacer is particularly helpful in children because it improves coordination and delivers more medication to the lungs rather than the mouth and throat. In more severe cases, adding ipratropium bromide can enhance the bronchodilatory effect. Oral syrup provides slower, less reliable onset, and intravenous albuterol is reserved for critical situations where inhaled delivery isn’t feasible.

During pediatric asthma episodes, the goal is rapid, effective bronchodilation delivered directly to the lungs. Inhaled beta-agonists achieve this best, and they can be given either by a nebulizer or by a metered-dose inhaler with a spacer. The spacer is particularly helpful in children because it improves coordination and delivers more medication to the lungs rather than the mouth and throat. In more severe cases, adding ipratropium bromide can enhance the bronchodilatory effect. Oral syrup provides slower, less reliable onset, and intravenous albuterol is reserved for critical situations where inhaled delivery isn’t feasible.